Clinical Trials
Samsung Bioepis Initiates Phase 3 Clinical Trial for SB15, Proposed Biosimilar to Eylea
Samsung Bioepis announced the initiation of Phase 3 clinical trial for SB15, the company's proposed biosimilar referencing Eylea® (aflibercept). The Phase 3 clinical trial...
Clinical Trials
Astrazeneca: Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1
AstraZeneca announced that selumetinib has been granted orphan drug designation (ODD) in Japan for the treatment of neurofibromatosis type 1 (NF1), a rare and...
Clinical Trials
LabCorp Introduces Xcellerate COVID-19 Clinical Study Solution
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, has deployed...
Clinical Trials
India’s 1st COVID-19 Vaccine -COVAXIN, Developed by Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials
Bharat Biotech has successfully developed COVAXIN™, India’s 1stvaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) -National Institute of...
Clinical Trials
Zealand Pharma announces first patient dosed in Phase 2 trial with long-acting GLP-1 dual agonist in obesity/diabetes
Zealand Pharma announced that the first patient has been dosed in a Phase 2 clinical trial of the long-acting GLP-1/glucagon dual agonist BI 456906,...
Clinical Trials
Symbiosis and AstraZeneca Sign Supply Agreement for Sterile Manufacture of COVID-19 Vaccine for Clinical Trials
Symbiosis Pharmaceutical Services, a specialist provider of pharmaceutical and vaccine development services, has announced it has signed a supply agreement with AstraZeneca for sterile...
Clinical Trials
PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19
PTC Therapeutics, Inc. announced that the U.S. FDA has authorized the initiation of a Phase 2/3 trial to investigate PTC299, a dihydroorotate dehydrogenase (DHODH)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read